Muhammad Umair Mushtaq/X
Jun 15, 2025, 09:17
Muhammad Umair Mushtaq: Excited to Share that I’ve Been Selected as a Next Generation Scholar for the National Cancer Institute’s Blood and Marrow Transplant Clinical Trials Network
Muhammad Umair Mushtaq, Associate Professor Hematologic Malignancies & Cellular Therapeutics at KU Medical Center, shared a post on X:
“Excited to share that I’ve been selected as a Next Generation Scholar for the National Cancer Institute’s Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 2025-2026! Grateful for the opportunity and honored to contribute to this groundbreaking work in advancing cancer therapies.”
Stay updated with Hemostasis Today.
-
Mar 2, 2026, 11:10AbQader Bedil: A Practical Diagnostic Workflow for Von Willebrand Disease
-
Mar 2, 2026, 11:06Advancing Visibility, Research, and Equitable Care on Rare Disease Day – WFH
-
Mar 2, 2026, 11:02Jecko Thachil: Exploring the Origins and Meaning of the Term Hemophilia
-
Mar 2, 2026, 10:56Emmanuel J Favaloro: The Most Popular Downloaded Papers in 2025 from Seminars in Thrombosis and Hemostasis
-
Mar 2, 2026, 10:48Akinchan Bhardwaj: Key Genomic Insights Transforming Coronary Artery Disease Prevention
-
Mar 2, 2026, 08:07Michael Makris: Exploring ADAMTS13, vWF Imbalance, and Endotheliopathy in Ischemic Stroke
-
Mar 2, 2026, 07:31Thrombocytopenia in Tropical Infectious Diseases – RPTH Journal
-
Mar 1, 2026, 13:17Michael Makris։ Extraterrestrial Regolith as a Trigger of the Intrinsic Coagulation Pathway
-
Mar 1, 2026, 13:11Strategic Planning Day to Shape The Future of Thrombosis and Haemostasis – THANZ